Jade Biosciences (JBIO) Minority Interest (2020 - 2021)
Jade Biosciences posted quarterly Minority Interest of $4.0 million for Q2 2021, down 67.44% on a QoQ basis from $12.3 million in Q4 2020.
Jade Biosciences (JBIO) has 2 years of Minority Interest data on file, last reported at $4.0 million in Q2 2021.
- For the quarter ending Q2 2021, Minority Interest changed N/A year-over-year to $4.0 million; the trailing twelve-month figure through Jun 2021 stood at $4.0 million (changed N/A YoY), and the FY2020 full-year result was $12.3 million, changed N/A from the prior year.
- Minority Interest for Q2 2021 stood at $4.0 million, down from $12.3 million in the prior quarter.
- Across five years, Minority Interest topped out at $12.3 million in Q4 2020 and bottomed at $4.0 million in Q2 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Jade Biosciences | 1.06 Bn | 1.06 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 4.00 Mn |
| Dec 31, 2020 | 12.29 Mn |